Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

NCT03298867 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
83
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen